28. Next-generation sequencing as a tool for precision medicine in clinical oncology

Next-generation sequencing (NGS) has become the most effective tool in the practice of clinical oncology. The technology allows for rapid detection of variants in DNA/RNA simultaneously in a single run within a few days. The results provide valuable information on diagnostic, prognostic and therapeutic targets, which help physicians determine the treatment strategy for cancer patients. Using Ion Torrent S5 platform, we have implemented the Ion Torrent 52-gene Oncomine Focus Assay (OFA) for solid tumors and 74-gene Oncomine Myeloid Assay (OMA) for hematological malignancies as routine clinical practice.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Source Type: research